Tan L, Salleh N
Molecules. 2024; 29(22).
PMID: 39598696
PMC: 11596561.
DOI: 10.3390/molecules29225307.
Zhang T, Sun G, Cheng X, Cao C, Cai Z, Zhou J
Mar Drugs. 2024; 22(11).
PMID: 39590781
PMC: 11595798.
DOI: 10.3390/md22110501.
Hai Y, Wei M, Wang C, Gu Y, Shao C
Mar Life Sci Technol. 2023; 3(4):488-518.
PMID: 37073258
PMC: 10077240.
DOI: 10.1007/s42995-021-00101-2.
Singh U, Gandhi H, Nikita , Bhattacharya J, Tandon R, Tiwari G
Arch Microbiol. 2023; 205(5):164.
PMID: 37012452
PMC: 10069739.
DOI: 10.1007/s00203-023-03514-y.
Ongpipattanakul C, Desormeaux E, DiCaprio A, van der Donk W, Mitchell D, Nair S
Chem Rev. 2022; 122(18):14722-14814.
PMID: 36049139
PMC: 9897510.
DOI: 10.1021/acs.chemrev.2c00210.
Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.
Sukmarini L
Molecules. 2022; 27(9).
PMID: 35565968
PMC: 9101517.
DOI: 10.3390/molecules27092619.
Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.
Reynolds D, Huesemann M, Edmundson S, Sims A, Hurst B, Cady S
Algal Res. 2021; 57:102331.
PMID: 34026476
PMC: 8128986.
DOI: 10.1016/j.algal.2021.102331.
Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs).
Fu Y, Jaarsma A, Kuipers O
Cell Mol Life Sci. 2021; 78(8):3921-3940.
PMID: 33532865
PMC: 7853169.
DOI: 10.1007/s00018-021-03759-0.
A Multi-Omics Characterization of the Natural Product Potential of Tropical Filamentous Marine Cyanobacteria.
Leao T, Wang M, Moss N, da Silva R, Sanders J, Nurk S
Mar Drugs. 2021; 19(1).
PMID: 33418911
PMC: 7825088.
DOI: 10.3390/md19010020.
Bioactive Compounds from Marine Heterobranchs.
Avila C, Angulo-Preckler C
Mar Drugs. 2020; 18(12).
PMID: 33371188
PMC: 7767343.
DOI: 10.3390/md18120657.
Natural Bioactive Thiazole-Based Peptides from Marine Resources: Structural and Pharmacological Aspects.
Dahiya R, Dahiya S, Fuloria N, Kumar S, Mourya R, Chennupati S
Mar Drugs. 2020; 18(6).
PMID: 32599909
PMC: 7345825.
DOI: 10.3390/md18060329.
Neo-Aplysiatoxin A Isolated from Okinawan Cyanobacterium .
Kawaguchi M, Satake M, Zhang B, Xiao Y, Fukuoka M, Uchida H
Molecules. 2020; 25(3).
PMID: 31978978
PMC: 7037229.
DOI: 10.3390/molecules25030457.
Natural Products from Cyanobacteria: Focus on Beneficial Activities.
Demay J, Bernard C, Reinhardt A, Marie B
Mar Drugs. 2019; 17(6).
PMID: 31151260
PMC: 6627551.
DOI: 10.3390/md17060320.
Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.
Gogineni V, Hamann M
Biochim Biophys Acta Gen Subj. 2017; 1862(1):81-196.
PMID: 28844981
PMC: 5918664.
DOI: 10.1016/j.bbagen.2017.08.014.
Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.
Ciavatta M, Lefranc F, Carbone M, Mollo E, Gavagnin M, Betancourt T
Med Res Rev. 2016; 37(4):702-801.
PMID: 27925266
PMC: 5484305.
DOI: 10.1002/med.21423.
Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity.
Lu Z, Harper M, Pond C, Barrows L, Ireland C, Wagoner R
J Nat Prod. 2012; 75(8):1436-40.
PMID: 22845329
PMC: 4176947.
DOI: 10.1021/np300270p.
Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria.
Sivonen K, Leikoski N, Fewer D, Jokela J
Appl Microbiol Biotechnol. 2010; 86(5):1213-25.
PMID: 20195859
PMC: 2854353.
DOI: 10.1007/s00253-010-2482-x.
Pharmacology and toxicology of pahayokolide A, a bioactive metabolite from a freshwater species of Lyngbya isolated from the Florida Everglades.
Berry J, Gantar M, Gawley R, Wang M, Rein K
Comp Biochem Physiol C Toxicol Pharmacol. 2005; 139(4):231-8.
PMID: 15683832
PMC: 2573041.
DOI: 10.1016/j.cca.2004.11.005.
